Marco Pavesi

14.6k total citations · 3 hit papers
68 papers, 5.3k citations indexed

About

Marco Pavesi is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Marco Pavesi has authored 68 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 37 papers in Hepatology and 12 papers in Pharmacology. Recurrent topics in Marco Pavesi's work include Liver Disease and Transplantation (37 papers), Liver Disease Diagnosis and Treatment (30 papers) and Drug-Induced Hepatotoxicity and Protection (12 papers). Marco Pavesi is often cited by papers focused on Liver Disease and Transplantation (37 papers), Liver Disease Diagnosis and Treatment (30 papers) and Drug-Induced Hepatotoxicity and Protection (12 papers). Marco Pavesi collaborates with scholars based in Spain, United Kingdom and France. Marco Pavesi's co-authors include Vicente Arroyo, Pere Ginès, Thierry Gustot, Mauro Bernardi, Richard Moreau, Paolo Angeli, Faouzi Saliba, Rajiv Jalan, Marco Domenicali and Juan Córdoba and has published in prestigious journals such as Circulation, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Marco Pavesi

66 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

2013 1.9k citations Richard Moreau, Rajiv Jalan et al. Gastroenterology profile →
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

2011 429 citations Javier Fernández, Juan Acevedo et al. Hepatology profile →
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis

2017 358 citations Javier Fernández, Juan Acevedo et al. Gut profile →

Peers

Marco Pavesi

HEPAT

EPIDE

SURGE

PHARM

NEPHR

Javier Fernández Spain

Puneeta Tandon Canada

Georg Auzinger United Kingdom

Marco Senzolo Italy

Claire Francoz France

Alexander Gimson United Kingdom

Jacqueline G. O’Leary United States

Elsa Solà Spain

Rafael Bañares Spain

Scott W. Biggins United States

Javier Fernández Spain

Marco Pavesi

5.5k ×1.4

HEPAT

4.9k ×1.4

EPIDE

2.2k ×1.4

SURGE

1.0k ×1.1

PHARM

828 ×1.9

NEPHR

Citations per year, relative to Marco Pavesi Marco Pavesi (= 1×) peers Javier Fernández

Countries citing papers authored by Marco Pavesi

Since Specialization

Citations

This map shows the geographic impact of Marco Pavesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Pavesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Pavesi more than expected).

Fields of papers citing papers by Marco Pavesi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Pavesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Pavesi. The network helps show where Marco Pavesi may publish in the future.

Co-authorship network of co-authors of Marco Pavesi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Pavesi. A scholar is included among the top collaborators of Marco Pavesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Pavesi. Marco Pavesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hernández‐Tejero, María, Marco Pavesi, Fátima Aziz, et al.. (2025). Multidrug-resistant colonization in decompensated cirrhosis outside the ICU predicts infection and poor outcomes. JHEP Reports. 8(3). 101707–101707.

Cappellari, A., Fabio Sessa, Aldo Bruno Giannì, et al.. (2023). Somatosensory tinnitus and temporomandibular disorders: A common association. Journal of Oral Rehabilitation. 50(11). 1181–1184. 5 indexed citations

Kondo, Takayuki, Stewart Macdonald, Cornelius Engelmann, et al.. (2021). The role of RIPK1 mediated cell death in acute on chronic liver failure. Cell Death and Disease. 13(1). 5–5. 31 indexed citations

Mezzano, Gabriel, Andrés Cárdenas, Ferrán Aguilar, et al.. (2021). Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Digestive and Liver Disease. 53(6). 738–745. 5 indexed citations

Sersté, Thomas, Hassane Njimi, Marco Pavesi, et al.. (2018). The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. Journal of Hepatology. 69(2). 318–324. 83 indexed citations

Fernández, Javier, Juan Acevedo, Reiner Wiest, et al.. (2017). Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 67(10). 1870–1880. 358 indexed citations breakdown →

Herdman, Mike, Jameel Nazir, Zalmaï Hakimi, et al.. (2017). Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial. Patient. 10(6). 677–686. 9 indexed citations

Angeli, Paolo, Ezequiel Rodríguez, Salvatore Piano, et al.. (2014). Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. Gut. 64(10). 1616–1622. 79 indexed citations

Cárdenas, Andrés, Elsa Solà, Ezequiel Rodríguez, et al.. (2014). Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Critical Care. 18(6). 700–700. 31 indexed citations

10.

Herdman, Michael, Marco Pavesi, Nancy Devlin, et al.. (2014). Using Eq-5d-3l And Oab-5d To Assess Changes In Health-Related Quality Of Life (Hrqol) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph). Value in Health. 17(3). A295–A295.

11.

Córdoba, Juan, Meritxell Ventura‐Cots, Macarena Simón‐Talero, et al.. (2013). Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). Journal of Hepatology. 60(2). 275–281. 227 indexed citations

12.

Acevedo, Juan, Javier Fernández, Verónica Prado, et al.. (2013). Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology. 58(5). 1757–1765. 104 indexed citations

13.

Cecchi, Roberto, et al.. (2011). Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.. PubMed. 146(2). 79–84. 1 indexed citations

14.

Martín–Llahí, Marta, Mónica Guevara, Aldo Torre, et al.. (2010). Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis. Gastroenterology. 140(2). 488–496.e4. 259 indexed citations

15.

González, M. Teresa, et al.. (2008). Efficacy of Intravenous Alfacalcidol in the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis. Nephron Clinical Practice. 108(2). c141–c147. 2 indexed citations

16.

Cabarrocas, X., et al.. (2006). Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 44(9). 443–448. 8 indexed citations

17.

Ranucci, Marco, Giuseppe Isgrò, Marco Pavesi, et al.. (2003). Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Critical Care Medicine. 31(1). 52–59. 72 indexed citations

18.

Lloreta, Josep, et al.. (2001). Prediction of recurrence and nucleolar features in node-negative breast carcinoma, ductal type, grade II. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 440(3). 280–284. 1 indexed citations

19.

Elosúa, Roberto, et al.. (1999). Relationship of lipoprotein(a) levels to physical activity and family history of coronary heart disease.. American Journal of Public Health. 89(3). 383–385. 8 indexed citations

20.

Sentı́, Mariano, et al.. (1998). Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. Clinical Biochemistry. 31(8). 647–651. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact